Illexcor Therapeutics is a biopharmaceutical company dedicated to the creation of next-gen oral therapies to treat patients ...

India's Zydus Lifesciences declared it would purchase an 85.6 per cent ownership in France's Amplitude Surgical for 256.8 ...

Zydus will carry out early-stage development. (Image Credits: Pixabay) Zydus Lifesciences Limited on Tuesday announced its focus on the development of a combination vaccine against shigellosis and ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation, will carry out ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

High Conviction Stocks Idea Attributes-Company: a) Sound / resilient business; b) Consistent strong financials; c) High growth potential; and d) High return on invested capital.Industry: a) Market ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The chapel was originally dedicated by the Reverend George Carey, who at the time in 1989 was the Bishop of Bath and Wells, and later served as the Archbishop of Canterbury. The room had a lectern ...

Maybe it seems odd to invoke the spirit of Bunty Kelly on matchday. But her life and memories carry a resonance only underlined by the sound of planes descending into Glasgow Airport.

Speaking on the development Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Limited said, “Preventives are the key to public health in both the developing and the developed world and vaccines ...